Xtl Biopharmaceuticals Ltd Stock Price Prediction
| XTLB Stock | USD 1.88 0.03 1.62% |
Oversold Vs Overbought
45
Oversold | Overbought |
Quarterly Earnings Growth (0.76) | Wall Street Target Price 30 |
Using XTL Biopharmaceutica hype-based prediction, you can estimate the value of XTL Biopharmaceuticals Ltd from the perspective of XTL Biopharmaceutica response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in XTL Biopharmaceutica to buy its stock at a price that has no basis in reality. In that case, they are not buying XTL because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
XTL Biopharmaceutica after-hype prediction price | USD 1.82 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
XTL |
XTL Biopharmaceutica After-Hype Price Prediction Density Analysis
As far as predicting the price of XTL Biopharmaceutica at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in XTL Biopharmaceutica or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of XTL Biopharmaceutica, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
XTL Biopharmaceutica Estimiated After-Hype Price Volatility
In the context of predicting XTL Biopharmaceutica's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on XTL Biopharmaceutica's historical news coverage. XTL Biopharmaceutica's after-hype downside and upside margins for the prediction period are 0.09 and 8.65, respectively. We have considered XTL Biopharmaceutica's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
XTL Biopharmaceutica is extremely dangerous at this time. Analysis and calculation of next after-hype price of XTL Biopharmaceuticals is based on 3 months time horizon.
XTL Biopharmaceutica Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as XTL Biopharmaceutica is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading XTL Biopharmaceutica backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with XTL Biopharmaceutica, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.36 | 6.77 | 0.06 | 0.05 | 9 Events / Month | 2 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.88 | 1.82 | 3.19 |
|
XTL Biopharmaceutica Hype Timeline
XTL Biopharmaceuticals is at this time traded for 1.88. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.05. XTL is expected to decline in value after the next headline, with the price expected to drop to 1.82. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -3.19%, whereas the daily expected return is at this time at -0.36%. The volatility of related hype on XTL Biopharmaceutica is about 4750.88%, with the expected price after the next announcement by competition of 1.93. The book value of the company was at this time reported as 0.01. The company recorded a loss per share of 0.03. XTL Biopharmaceuticals last dividend was issued on the 10th of February 2017. The entity had 1:5 split on the 10th of February 2017. Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out XTL Biopharmaceutica Basic Forecasting Models to cross-verify your projections.XTL Biopharmaceutica Related Hype Analysis
Having access to credible news sources related to XTL Biopharmaceutica's direct competition is more important than ever and may enhance your ability to predict XTL Biopharmaceutica's future price movements. Getting to know how XTL Biopharmaceutica's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how XTL Biopharmaceutica may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TFFP | Tff Pharmaceuticals | (0.13) | 4 per month | 0.00 | (0.13) | 11.28 | (12.99) | 95.77 | |
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| INBX | Inhibrx | 1.00 | 6 per month | 2.72 | 0.01 | 5.54 | (6.11) | 16.80 | |
| ELVN | Enliven Therapeutics | (0.55) | 9 per month | 2.18 | 0.01 | 5.84 | (4.07) | 12.96 |
XTL Biopharmaceutica Additional Predictive Modules
Most predictive techniques to examine XTL price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for XTL using various technical indicators. When you analyze XTL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About XTL Biopharmaceutica Predictive Indicators
The successful prediction of XTL Biopharmaceutica stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as XTL Biopharmaceuticals Ltd, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of XTL Biopharmaceutica based on analysis of XTL Biopharmaceutica hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to XTL Biopharmaceutica's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to XTL Biopharmaceutica's related companies. | 2023 | 2024 (projected) | Days Sales Outstanding | 22.33 | 21.21 | PTB Ratio | 2.3 | 2.41 |
Story Coverage note for XTL Biopharmaceutica
The number of cover stories for XTL Biopharmaceutica depends on current market conditions and XTL Biopharmaceutica's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that XTL Biopharmaceutica is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about XTL Biopharmaceutica's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
XTL Biopharmaceutica Short Properties
XTL Biopharmaceutica's future price predictability will typically decrease when XTL Biopharmaceutica's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of XTL Biopharmaceuticals Ltd often depends not only on the future outlook of the potential XTL Biopharmaceutica's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. XTL Biopharmaceutica's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 544.9 M | |
| Cash And Short Term Investments | 2 M |
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |